Skip to main content
Tech.euFundingExplorerBeta

Vivent

Vivent is an electroceuticals company that uses biosignals to develop medical solutions and monitoring technologies for plant health.

Vivent has raised €2.3M across 2 funding rounds from 3 investors, most recently a Debt round in Jan 2022. Based in Gland, Switzerland; active in Agritech. Data as of 28 Oct 2026.

Total raised
€2.3M
€2,280,584
Funding rounds
2
Investors
3
distinct backers
Active since
2021-11
latest 2022-01

Funding by year

EUR raised per year
Vivent — funding by year — interactive chart.
Data table
Vivent — funding by year
2021€1.8M
2022€481k

Signals

High confidence
Raise-next likelihood7
base rate 45% for Debt
  • ▼ Dormant (no round in 3+ cohort gaps)
  • ▼ Down/flat last round
  • ▼ Low backer re-investment
Exit likelihood7
base rate 11% (2+ rounds)
  • ▲ 5y since founding (typical exit age)
  • ▼ No recent equity round (debt-only or quiet)

Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

2 rounds
DateStageAmountInvestors
2022-01-31Debt€481kFoundation for Technological Innovation (FIT)View deal →
2021-11-29Other€1.8MAstanor Ventures,ePlantView deal →

Related news

Similar companies

same sector or country

Global coverage: FundingData